Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.830 | 2.150 | 0.3200 |
| Révision: | $117.41M | $116.59B | $4.41M |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.710 | 2.000 | 0.2900 |
| Révision: | $120.64M | $121.00M | -$10.05M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.910 | 2.280 | 0.3700 |
| Révision: | $118.86M | $137.52M | $3.12M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.970 | 1.940 | -0.0300 |
| Révision: | $120.77M | $115.13M | -$4.18M |
